EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exosomal miR ‐199a‐3p Secreted From Cancer‐Associated Adipocytes Promotes Pancreatic Cancer Progression

Kazuyoshi Noda, Yasushi Sato iD, Yasuyuki Okada, Kensei Nishida, Yutaka Kawano, Toshihito Tanahashi, Masahiro Bando, Koichi Okamoto, Masanori Takehara iD, Masahiro Sogabe iD, Hiroshi Miyamoto, Kei Daizumoto und 2 weitere

Cancer Medicine · 2024-10 · 13 (20)

DOI: 10.1002/cam4.70265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 21.10.2024. Verfasst von Kazuyoshi Noda und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Oncology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan. Hauptthemen laut MEDLINE: MicroRNAs, Exosomes, Pancreatic Neoplasms, Disease Progression. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer. Recent studies indicated that cancer‐associated adipocytes (CAAs) play crucial roles in tumor progression; however, the precise mechanism remains unknown. Here, we analyzed specific exosomal microRNAs (miRNA) signatures derived from pancreatic CAAs to investigate their role in cancer progression.

Methods

CAAs were generated by co‐culturing human adipocytes with human pancreatic cancer cells, and exosomes were isolated from the CAA‐conditioned medium (CAA‐CM). Small RNA‐seq analysis was used to identify differentially expressed miRNAs in these exosomes. The effects of miRNAs on cell proliferation, migration/invasion, and drug sensitivity were examined. Luciferase reporter assays, real‐time polymerase chain reaction, and western blotting were performed to investigate the molecular mechanisms of the miRNAs. The clinical relevance of the miRNAs was investigated using publicly available data and our cohort of patients with PDAC. Results miR‐199a‐3p expression was significantly increased in CAA‐CM‐derived exosomes. CAA‐derived exosomes transferred miR‐199a‐3p to pancreatic cancer cells. Transfection with miR‐199a‐3p increased the proliferation, invasion, migration, and drug resistance of pancreatic cancer cells by downregulating SOCS7, increasing STAT3 phosphorylation, and upregulating SAA1 expression. High tissue miR‐199a‐3p expression is correlated with poor prognosis in patients with PDAC. Liquid biopsies revealed that exosomal miR‐199a‐3p could accurately differentiate patients with PDAC from healthy controls. Multivariate survival analysis indicated that miR‐199a is an independent prognostic factor for PDAC. Conclusion miR‐199a‐3p in CAA‐derived exosomes contributes to the malignant transformation of pancreatic cancer via the SOCS7/STAT3/SAA1 pathway, suggesting its potential as a biomarker and therapeutic target for PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsExosomesPancreatic NeoplasmsDisease ProgressionCell ProliferationCarcinoma, Pancreatic DuctalAdipocytesGene Expression Regulation, NeoplasticHumansCell Line, TumorCell MovementSTAT3 Transcription FactorPrognosisBiomarkers, TumorFemaleMaleDrug Resistance, Neoplasm

Stichwörter der Autor:innen

biomarkercancer‐associated adipocytesmiR‐199a‐3ppancreatic ductal adenocarcinoma

Substanzen

MicroRNAsmirn199 microRNA, humanSTAT3 Transcription FactorBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Gastroenterology and Oncology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
  • Department of Community Medicine for Gastroenterology and Oncology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
  • Department of Pathophysiology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
  • Department of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.

ORCID-Profile: Yasushi Sato, Masanori Takehara, Masahiro Sogabe, Tetsuji Takayama

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Noda, K., Sato, Y., Okada, Y., Nishida, K., Kawano, Y., Tanahashi, T., Bando, M., Okamoto, K., Takehara, M., Sogabe, M., Miyamoto, H., Daizumoto, K., Kanayama, H., & Takayama, T. (2024). Exosomal miR ‐199a‐3p Secreted From Cancer‐Associated Adipocytes Promotes Pancreatic Cancer Progression. Cancer Medicine, 13(20). https://doi.org/10.1002/cam4.70265

Vancouver

Noda K, Sato Y, Okada Y, Nishida K, Kawano Y, Tanahashi T, et al. Exosomal miR ‐199a‐3p Secreted From Cancer‐Associated Adipocytes Promotes Pancreatic Cancer Progression. Cancer Medicine. 2024;13(20). doi:10.1002/cam4.70265

BibTeX
@article{Noda2024,
  author = {Noda, Kazuyoshi and Sato, Yasushi and Okada, Yasuyuki and Nishida, Kensei and Kawano, Yutaka and Tanahashi, Toshihito and Bando, Masahiro and Okamoto, Koichi and Takehara, Masanori and Sogabe, Masahiro and Miyamoto, Hiroshi and Daizumoto, Kei and Kanayama, Hiroomi and Takayama, Tetsuji},
  title = {Exosomal miR ‐199a‐3p Secreted From Cancer‐Associated Adipocytes Promotes Pancreatic Cancer Progression},
  journal = {Cancer Medicine},
  year = {2024},
  volume = {13},
  number = {20},
  doi = {10.1002/cam4.70265}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche